ImmunoGen, Inc. Quarterly Common Stock, Shares, Issued from Q2 2011 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
ImmunoGen, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q2 2011 to Q3 2023.
  • ImmunoGen, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2023 was 266M shares, a 20.4% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 266M +45.1M +20.4% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 249M +28.1M +12.7% Jun 30, 2023 10-Q 2023-07-31
Q1 2023 226M +5.53M +2.51% Mar 31, 2023 10-Q 2023-04-28
Q4 2022 226M +5.69M +2.58% Dec 31, 2022 10-Q 2023-11-02
Q3 2022 221M +18.3M +9.04% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 221M +20.4M +10.2% Jun 30, 2022 10-Q 2022-08-01
Q1 2022 221M +20.6M +10.3% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 220M +25.4M +13% Dec 31, 2021 10-K 2023-03-01
Q3 2021 202M +27.9M +16% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 200M +25.7M +14.7% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 200M +25.7M +14.7% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 195M +44.9M +29.9% Dec 31, 2020 10-K 2022-02-28
Q3 2020 175M +24.9M +16.6% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 175M +24.7M +16.4% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 174M +24.8M +16.6% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 150M +736K +0.49% Dec 31, 2019 10-K 2021-03-01
Q3 2019 150M +150M +100329% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 150M +150M +100480% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 149M +16.4M +12.3% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 149M +16.9M +12.7% Dec 31, 2018 10-K 2020-03-11
Q3 2018 149K* -115M -99.9% Sep 30, 2018 10-Q 2018-11-02
Q2 2018 149K* -89.4M -99.8% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 133M +43.7M +48.9% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 133M +45.2M +51.8% Dec 31, 2017 10-K 2019-03-01
Q3 2017 116M +28.2M +32.4% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 89.6M +2.39M +2.74% Jun 30, 2017 10-Q 2017-08-04
Q1 2017 89.3M +2.27M +2.61% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 87.3M +261K +0.3% Dec 31, 2016 10-K 2018-03-07
Q3 2016 87.3M +333K +0.38% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 87.2M +630K +0.73% Jun 30, 2016 10-KT 2017-03-03
Q1 2016 87.1M +943K +1.1% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 87M +959K +1.11% Dec 31, 2015 10-Q 2016-02-04
Q3 2015 87M +1.05M +1.23% Sep 30, 2015 10-Q 2015-10-30
Q2 2015 86.6M +676K +0.79% Jun 30, 2015 10-KT 2017-03-03
Q1 2015 86.1M +327K +0.38% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 86.1M +452K +0.53% Dec 31, 2014 10-Q 2015-02-05
Q3 2014 85.9M +658K +0.77% Sep 30, 2014 10-Q 2014-10-30
Q2 2014 85.9M +1.18M +1.39% Jun 30, 2014 10-K 2015-08-27
Q1 2014 85.8M +1.37M +1.62% Mar 31, 2014 10-Q 2014-05-02
Q4 2013 85.6M +1.44M +1.71% Dec 31, 2013 10-Q 2014-02-05
Q3 2013 85.3M +1.15M +1.37% Sep 30, 2013 10-Q 2013-10-29
Q2 2013 84.7M +6.97M +8.96% Jun 30, 2013 10-K 2014-08-28
Q1 2013 84.4M +7.25M +9.39% Mar 31, 2013 10-Q 2013-05-06
Q4 2012 84.2M +7.49M +9.77% Dec 31, 2012 10-Q 2013-01-30
Q3 2012 84.1M +7.7M +10.1% Sep 30, 2012 10-Q 2012-10-31
Q2 2012 77.8M +1.48M +1.94% Jun 30, 2012 10-K 2013-08-29
Q1 2012 77.2M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 76.7M Dec 31, 2011 10-Q 2012-01-31
Q3 2011 76.4M Sep 30, 2011 10-Q 2011-10-31
Q2 2011 76.3M Jun 30, 2011 10-K 2012-08-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.